Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA | 7 | 2018 | 839 | 2.060 |
Why?
|
| Nanostructures | 7 | 2014 | 178 | 1.790 |
Why?
|
| Ionic Liquids | 5 | 2022 | 8 | 1.490 |
Why?
|
| Muramidase | 3 | 2022 | 46 | 0.860 |
Why?
|
| Protein Unfolding | 2 | 2020 | 13 | 0.720 |
Why?
|
| Biocompatible Materials | 3 | 2014 | 148 | 0.520 |
Why?
|
| Polymers | 4 | 2014 | 322 | 0.490 |
Why?
|
| Elastin | 2 | 2013 | 10 | 0.490 |
Why?
|
| Nanotechnology | 2 | 2018 | 135 | 0.480 |
Why?
|
| Drug Carriers | 2 | 2014 | 179 | 0.460 |
Why?
|
| Surface-Active Agents | 2 | 2015 | 113 | 0.430 |
Why?
|
| Drug Delivery Systems | 3 | 2014 | 325 | 0.430 |
Why?
|
| Oligopeptides | 1 | 2014 | 133 | 0.420 |
Why?
|
| Inovirus | 1 | 2013 | 1 | 0.420 |
Why?
|
| Cell Surface Display Techniques | 1 | 2013 | 6 | 0.410 |
Why?
|
| Fibroblasts | 2 | 2014 | 392 | 0.400 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2014 | 245 | 0.400 |
Why?
|
| DNA, Antisense | 1 | 2011 | 17 | 0.380 |
Why?
|
| Gene Transfer Techniques | 1 | 2013 | 315 | 0.350 |
Why?
|
| Butadienes | 1 | 2010 | 11 | 0.340 |
Why?
|
| Polyethylene | 1 | 2010 | 10 | 0.340 |
Why?
|
| Viruses | 1 | 2011 | 80 | 0.330 |
Why?
|
| Fibrinogen | 1 | 2010 | 32 | 0.330 |
Why?
|
| Peptides | 2 | 2013 | 574 | 0.320 |
Why?
|
| DNA Restriction Enzymes | 1 | 2009 | 35 | 0.320 |
Why?
|
| Coliphages | 1 | 2008 | 17 | 0.290 |
Why?
|
| Protein Folding | 2 | 2024 | 266 | 0.280 |
Why?
|
| Virus Assembly | 1 | 2008 | 53 | 0.280 |
Why?
|
| Thermodynamics | 2 | 2020 | 195 | 0.250 |
Why?
|
| Molecular Dynamics Simulation | 3 | 2022 | 121 | 0.240 |
Why?
|
| Models, Biological | 1 | 2010 | 1180 | 0.230 |
Why?
|
| Protein Structure, Secondary | 4 | 2024 | 260 | 0.220 |
Why?
|
| Salts | 1 | 2024 | 15 | 0.220 |
Why?
|
| Chickens | 2 | 2020 | 94 | 0.200 |
Why?
|
| Circular Dichroism | 2 | 2013 | 108 | 0.200 |
Why?
|
| Imidazoles | 2 | 2020 | 80 | 0.200 |
Why?
|
| Temperature | 3 | 2016 | 309 | 0.190 |
Why?
|
| Surface Properties | 4 | 2011 | 278 | 0.190 |
Why?
|
| Water | 3 | 2016 | 307 | 0.180 |
Why?
|
| HeLa Cells | 2 | 2014 | 533 | 0.180 |
Why?
|
| Transition Temperature | 1 | 2020 | 6 | 0.180 |
Why?
|
| Organophosphates | 1 | 2020 | 16 | 0.170 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 364 | 0.170 |
Why?
|
| Protein Stability | 1 | 2020 | 91 | 0.170 |
Why?
|
| Nucleic Acid Conformation | 2 | 2012 | 242 | 0.170 |
Why?
|
| Animals | 7 | 2020 | 20584 | 0.160 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2018 | 27 | 0.150 |
Why?
|
| Polymerization | 1 | 2018 | 36 | 0.150 |
Why?
|
| Macromolecular Substances | 1 | 2018 | 160 | 0.140 |
Why?
|
| Molecular Biology | 1 | 2018 | 67 | 0.140 |
Why?
|
| Integrins | 2 | 2014 | 109 | 0.130 |
Why?
|
| Silicones | 1 | 2015 | 14 | 0.120 |
Why?
|
| Vascular Access Devices | 1 | 2015 | 15 | 0.120 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2015 | 30 | 0.120 |
Why?
|
| Catheters, Indwelling | 1 | 2015 | 69 | 0.120 |
Why?
|
| Peptide Library | 2 | 2012 | 36 | 0.110 |
Why?
|
| Solutions | 2 | 2012 | 64 | 0.110 |
Why?
|
| Aptamers, Nucleotide | 1 | 2014 | 23 | 0.110 |
Why?
|
| Adsorption | 3 | 2010 | 83 | 0.110 |
Why?
|
| Focal Adhesions | 1 | 2014 | 24 | 0.110 |
Why?
|
| Nanomedicine | 1 | 2014 | 25 | 0.110 |
Why?
|
| NIH 3T3 Cells | 1 | 2014 | 99 | 0.110 |
Why?
|
| Renal Dialysis | 1 | 2015 | 197 | 0.110 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2013 | 260 | 0.110 |
Why?
|
| Cell Adhesion | 1 | 2014 | 207 | 0.110 |
Why?
|
| Fluorescence | 1 | 2013 | 91 | 0.100 |
Why?
|
| Endocytosis | 1 | 2013 | 152 | 0.100 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2012 | 78 | 0.100 |
Why?
|
| Cellular Microenvironment | 1 | 2012 | 21 | 0.100 |
Why?
|
| Fibronectins | 1 | 2012 | 43 | 0.100 |
Why?
|
| Molecular Probes | 1 | 2012 | 29 | 0.100 |
Why?
|
| Ethanol | 1 | 2015 | 321 | 0.090 |
Why?
|
| Mice | 4 | 2014 | 10804 | 0.090 |
Why?
|
| Phosphatidylserines | 1 | 2011 | 13 | 0.090 |
Why?
|
| Unilamellar Liposomes | 1 | 2011 | 9 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 455 | 0.090 |
Why?
|
| Phosphatidylcholines | 1 | 2011 | 35 | 0.090 |
Why?
|
| Viral Proteins | 1 | 2013 | 259 | 0.090 |
Why?
|
| Ion Exchange | 1 | 2010 | 2 | 0.090 |
Why?
|
| Photoelectron Spectroscopy | 1 | 2010 | 2 | 0.090 |
Why?
|
| Static Electricity | 1 | 2010 | 166 | 0.080 |
Why?
|
| Membranes, Artificial | 2 | 2011 | 45 | 0.080 |
Why?
|
| Biomimetics | 1 | 2010 | 29 | 0.080 |
Why?
|
| Biomechanical Phenomena | 1 | 2011 | 269 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2011 | 669 | 0.080 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2009 | 25 | 0.080 |
Why?
|
| Deoxyribonuclease I | 1 | 2009 | 41 | 0.080 |
Why?
|
| Exodeoxyribonucleases | 1 | 2009 | 29 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 1594 | 0.070 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2008 | 31 | 0.070 |
Why?
|
| Joint Diseases | 1 | 2008 | 19 | 0.070 |
Why?
|
| Cartilage | 1 | 2008 | 34 | 0.070 |
Why?
|
| Scattering, Radiation | 1 | 2008 | 74 | 0.070 |
Why?
|
| Base Sequence | 1 | 2009 | 1333 | 0.070 |
Why?
|
| Light | 1 | 2008 | 201 | 0.070 |
Why?
|
| Phase Transition | 1 | 2005 | 21 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2011 | 1528 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1992 | 0.060 |
Why?
|
| Fluid Therapy | 1 | 2022 | 49 | 0.050 |
Why?
|
| Humans | 3 | 2014 | 62682 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2008 | 517 | 0.050 |
Why?
|
| Solubility | 2 | 2016 | 179 | 0.050 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2016 | 44 | 0.030 |
Why?
|
| Protein Binding | 2 | 2012 | 1601 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2015 | 30 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2015 | 75 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2015 | 38 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2015 | 133 | 0.030 |
Why?
|
| Micelles | 1 | 2015 | 80 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2015 | 112 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 73 | 0.030 |
Why?
|
| Catheter-Related Infections | 1 | 2015 | 42 | 0.030 |
Why?
|
| Materials Testing | 1 | 2015 | 83 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2015 | 223 | 0.030 |
Why?
|
| Heparin | 1 | 2015 | 116 | 0.030 |
Why?
|
| Time Factors | 2 | 2015 | 3742 | 0.030 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2012 | 27 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 234 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2011 | 15 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 139 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2015 | 494 | 0.020 |
Why?
|
| Bacteriophages | 1 | 2012 | 61 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2011 | 63 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2011 | 139 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 670 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 786 | 0.020 |
Why?
|
| Collagen Type II | 1 | 2008 | 12 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2012 | 1143 | 0.020 |
Why?
|
| Injections, Intra-Articular | 1 | 2008 | 51 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 2154 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 308 | 0.020 |
Why?
|
| Lung | 1 | 2012 | 939 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2008 | 173 | 0.020 |
Why?
|
| Polypropylenes | 1 | 2005 | 6 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2005 | 29 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 1003 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 2005 | 48 | 0.020 |
Why?
|
| Avidin | 1 | 2004 | 11 | 0.010 |
Why?
|
| Adhesiveness | 1 | 2004 | 13 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2004 | 188 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2005 | 168 | 0.010 |
Why?
|
| Lysine | 1 | 2004 | 82 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2004 | 384 | 0.010 |
Why?
|